Maze Therapeutics MAZE
NASDAQ MAZE
$26.65 -0.53 (-1.95%)
At close: Oct 1, 2026 · 4:00 PM EDT

Maze Therapeutics (MAZE) Gross Profit (2025 - 2026)

Updated

Maze Therapeutics (MAZE) posted Gross Profit of $18.21 million for Q1 2026, compared with -$1.19 million a year earlier.

Analysis

Maze Therapeutics (MAZE) Gross Profit (2025 - 2026) Analysis & Trends

For FY2025, Maze Therapeutics' Gross Profit came in at -$6.31 million.

  • In prior years, Maze Therapeutics' Gross Profit was $163.89 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Maze Therapeutics 1.51 Bn 1.51 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 18.21 Mn
Mar 31, 2025 -1.19 Mn
API Access

Maze Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=MAZE&period=max&api_key=YOUR_API_KEY